期刊文献+

猫角膜内皮细胞与人脉络膜色素瘤细胞共培养后增殖能力的变化 被引量:1

Proliferation of cat corneal endothelial cells co-cultured with OCM-1 cells
暂未订购
导出
摘要 目的观察猫角膜内皮细胞(CEC)与人脉络膜黑色素瘤细胞(OCM-1)共培养后增殖能力及细胞周期的变化。方法将角膜内皮细胞分别与肿瘤细胞OCM-1、兔角膜基质细胞在Transwell体系中共培养,通过流式细胞术观察内皮细胞增殖能力及细胞周期的变化。结果与空白对照组角膜内皮细胞周期比较,肿瘤细胞组与基质细胞组角膜内皮细胞S期细胞比例增加,G1期细胞比例下降,肿瘤组增加幅度高于基质细胞组的。肿瘤细胞组角膜内皮细胞S期细胞比例比空白对照组的平均增加近19%,增殖能力显著提高。结论与肿瘤细胞OCM-1共培养能促进角膜内皮细胞增殖。 Objective To study the changes in the proliferation and cell cycle of cat corneal endothelial cells (CECs) co - cultured with choroidal melanoma cells ( OCM - 1 ). Methods The Transwell co - culture systems were divided into there groups: experimental group, positive control group and control group. CECs were co -cultured with OCM - 1 cells in the experimental group. CECs were co - cultured with rabbit corneal stromal cells in the positive group. CECs were cultured alone in the control group. The changes in the proliferation and cell cycle of cat corneal endothelial cells were examined by flow cytometry after co - culture. Results Compared with the control, the portions of CECs in S - phase of OCM - 1 group and stromal - cells group increased and the portion of cat endothelial cells in G1 - phase of the two groups decreased. Changes of cell cycle of CECs in OCM - 1 group were more significant than in stromal - cell group. The portion of CECs in S - phase of OCM - 1 group increased nearly 19%, indicating a significant enhancement of cell proliferation. Conclusion CECs co - cultured with OCM - 1 cells can promote proliferation.
出处 《广东医学》 CAS CSCD 北大核心 2008年第2期191-193,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:39870855) 广东省科技计划基金资助项目(编号:2KM05203S) 暨南大学侨办重点学科基金资助项目(编号:51205004)
关键词 角膜内皮细胞 Transwell体系 共培养 增殖 Corneal endothelial cell Transwell system Co -culture Proliferation
  • 相关文献

参考文献5

二级参考文献45

  • 1钱利华,李荣,王金花,回允中.p53及p21蛋白在胆囊癌及肝外胆管癌的表达[J].中华病理学杂志,2003,32(5):454-455. 被引量:1
  • 2向明明 杨恬 见:章静波 林建银 杨恬.细胞外基质[A].见:章静波,林建银,杨恬.医学分子细胞生物学[C].北京:中国协和医科大学出版社,2002.47-56.
  • 3Eatock MM,Schatzlein A,Kaye SB. Tumor vasculature as a target for anticancer therapy[J]. Cancer Treat Rev,2000,26 (3):191
  • 4Bioemendal HJ,Logtenberg T,Voest EE. New strategies in anti-vascular cancer therapy[J]. Eur J Clin Invest,1999,29(9):802
  • 5Raymond M. Schiffelers,Gerban A,et al. Anti-tumor efficacy of tumor vascular-targeted liposomal doxorubicin[J]. J controlled release,2003,91:115
  • 6Nicolson GL. Tumor cell interactions with the vascular endothelium and their role in cancer metastasis[J]. EXS,1995,74:123
  • 7Papahadjopoulos D,Allen TM,Gabizon A,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy[J]. Proc Natl Acad,Sci USA,1991,88:11460
  • 8Fan Yuan. Transvascular drug delivery in solid tumors[J]. Seminars in Radiation Oncology,1998,8(3):164
  • 9Lin P,Buxton JA,Acheson A,et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2[J]. Proc Natl Acad Sci USA,1998,95:8829
  • 10David W. Lincoln II,Bove K. Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model[J]. Breast Cancer Research and Treatment,2003,78:167

共引文献32

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部